Healthcare and Life Science
Innovating Healthcare, Shaping the Future
Strategic Partnership between China MedTech Entrepreneurship Camp and EFEC
How future-ready is your school’s or business’s IT?
➡️ How do you feel about the technology you use in your school or business? A recent study found that 90% of managers or business leads felt confident that their IT systems today are “best in class”.❓ But how about tomorrow?💡The same study showed that:➡️ Only 39% of business leader...
Medicilon completed full sets of non-clinical research projects for new drugs such as ophthalmic solutions or intravitreal injections
Medicilon has been conducting comprehensive non-clinical research for ophthalmic drugs since 2013, with extensive experience from active pharmaceutical ingredients and formulations to pharmacodynamics, pharmacokinetics, and safety assessments, and has contributed to the approval of mult...
Medicilon large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development
With the advent of the era of precision medicine and the deepening understanding of disease mechanisms, large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development. ...
Navigating the EU’s General Product Safety Regulations (GPSR)
Webinar on Tuesday, 10 December 2024, from 1:00 PM to 2:30 PM UK Time to help businesses prepare for the General Product Safety Regulation (GPSR) deadline on 13 December 2024. ...
Newcells Biotech raises additional funding from investors
Newcastle, UK, 5th December 2024: Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, announces it has raised a further £1.2m from existing investors Me...
FairJourney Biologics appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering
Appointment of industry expert to drive innovation and excellence in antibody discovery and engineering, to support market demand from global pharma and biotech ...
Strategies for coping with ILD
Interstitial lung disease (ILD) is a chronic and life-limiting lung disease with no curative options which can take a significant emotional toll on sufferers. A diagnosis of ILD comes with feelings of anxiety and uncertainty about the future. As the condition progresses, patients are al...
evitria Partners with Sapio Sciences to streamline antibody workflow management and reporting
Leading antibody expression service provider implements Sapio’s ELN and Report Builder for advanced sample tracking and data management ...
Orbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics development
Oxford, UK, and Springfield, NJ, USA, 3rd December 2024: Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, today announced an extension to their research collaboration to ...